{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:51:41Z","timestamp":1791557501385,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32571493"],"award-info":[{"award-number":["32571493"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403671"],"award-info":[{"award-number":["82403671"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Gallbladder cancer (GBC) is the most aggressive malignancy of the biliary tract, and its molecular drivers remain insufficiently understood. SIVA1 (apoptosis regulatory protein Siva 1) has been implicated in the regulation of cell survival, but its function in GBC has not been defined. In this study, we found that SIVA1 expression was elevated in GBC tissues and cell lines, and high SIVA1 expression was associated with poor patient prognosis. Gain- and loss-of-function experiments demonstrated that SIVA1 promoted GBC cell proliferation and migration in vitro and facilitated tumor growth in nude mice xenograft model. Mechanistically, SIVA1 was subject to ubiquitin-proteasome-mediated degradation, and we identified C2ORF68 as a binding partner that reduced SIVA1 ubiquitination and stabilized its protein level. Stabilized SIVA1 in turn increased the expression of the anti-apoptotic protein BCL-2, thereby enhancing cell survival. These findings indicate that C2ORF68-mediated stabilization of SIVA1 promotes GBC progression through BCL-2-dependent anti-apoptotic signaling, supporting SIVA1 as a potential therapeutic target.<\/jats:p>","DOI":"10.1038\/s41420-026-03279-5","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T17:12:43Z","timestamp":1785431563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["C2ORF68 stabilizes SIVA1 to upregulate BCL-2 and suppress apoptosis in gallbladder cancer"],"prefix":"10.1038","volume":"12","author":[{"given":"Xuanjia","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3853-5126","authenticated-orcid":false,"given":"Yangyang","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2806-2874","authenticated-orcid":false,"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"3279_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5114\/ceh.2019.85166","volume":"5","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Thandra KC, Barsouk A. Epidemiology of gallbladder cancer. Clin Exp Hepatol. 2019;5:93\u2013102.","journal-title":"Clin Exp Hepatol"},{"key":"3279_CR2","first-page":"99","volume":"6","author":"R Hundal","year":"2014","unstructured":"Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99\u2013109.","journal-title":"Clin Epidemiol"},{"key":"3279_CR3","doi-asserted-by":"crossref","unstructured":"Roa JC, Garc\u00eda P, Kapoor VK, Maithel SK, Javle M, Koshiol J. Gallbladder cancer. Nat Rev Dis Primers. 2022;8:69.","DOI":"10.1038\/s41572-022-00398-y"},{"key":"3279_CR4","first-page":"221","volume":"3","author":"M Rakic","year":"2014","unstructured":"Rakic M, Patrlj L, Kopljar M, Klicek R, Kolovrat M, Loncar B, et al. Gallbladder cancer. HepatoBiliary Surg Nutr. 2014;3:221\u201326.","journal-title":"HepatoBiliary Surg Nutr"},{"key":"3279_CR5","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1097\/MD.0000000000000131","volume":"93","author":"X Wan","year":"2014","unstructured":"Wan X, Zhang H, Chen C, Yang X, Wang A, Zhu C, et al. Clinicopathological features of gallbladder papillary adenocarcinoma. Med (Balt). 2014;93:e131.","journal-title":"Med (Balt)"},{"key":"3279_CR6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.12998\/wjcc.v3.i3.231","volume":"3","author":"AN Dwivedi","year":"2015","unstructured":"Dwivedi AN, Jain S, Dixit R. Gall bladder carcinoma: aggressive malignancy with protean loco-regional and distant spread. World J Clin Cases. 2015;3:231\u201344.","journal-title":"World J Clin Cases"},{"key":"3279_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41392-020-00324-2","volume":"5","author":"X Song","year":"2020","unstructured":"Song X, Hu Y, Li Y, Shao R, Liu F, Liu Y. Overview of current targeted therapy in gallbladder cancer. Signal Transduct Target Ther. 2020;5:230.","journal-title":"Signal Transduct Target Ther"},{"key":"3279_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/jhbp.1219","volume":"30","author":"T Ioka","year":"2023","unstructured":"Ioka T, Kanai M, Kobayashi S, Sakai D, Eguchi H, Baba H, et al. Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401- MITSUBA). J Hepatobiliary Pancreat Sci. 2023;30:102\u201310.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"3279_CR9","doi-asserted-by":"publisher","first-page":"6346","DOI":"10.1073\/pnas.94.12.6346","volume":"94","author":"KV Prasad","year":"1997","unstructured":"Prasad KV, Ao Z, Yoon Y, Wu MX, Rizk M, Jacquot S, et al. CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc Natl Acad Sci USA. 1997;94:6346\u201351.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3279_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s13238-012-2018-5","volume":"3","author":"Y Mei","year":"2012","unstructured":"Mei Y, Wu M. Multifaceted functions of Siva-1: more than an Indian God of Destruction. Protein Cell. 2012;3:117\u201322.","journal-title":"Protein Cell"},{"key":"3279_CR11","doi-asserted-by":"publisher","first-page":"7174","DOI":"10.1038\/sj.onc.1203144","volume":"18","author":"Y Yoon","year":"1999","unstructured":"Yoon Y, Ao Z, Cheng Y, Schlossman SF, Prasad KV. Murine Siva-1 and Siva-2, alternate splice forms of the mouse Siva gene, both bind to CD27 but differentially transduce apoptosis. Oncogene. 1999;18:7174\u20139.","journal-title":"Oncogene"},{"key":"3279_CR12","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.4049\/jimmunol.172.7.4008","volume":"172","author":"B Py","year":"2004","unstructured":"Py B, Slomianny C, Auberger P, Petit PX, Benichou S. Siva-1 and an alternative splice form lacking the death domain, Siva-2, similarly induce apoptosis in T lymphocytes via a caspase-dependent mitochondrial pathway. J Immunol. 2004;172:4008\u201317.","journal-title":"J Immunol"},{"key":"3279_CR13","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1590\/1414-431X20132833","volume":"46","author":"JY Chen","year":"2013","unstructured":"Chen JY, Yang LX, Huang ZF. The N-terminal 33 amino acid domain of Siva-1 is sufficient for nuclear localization. Braz J Med Biol Res. 2013;46:1021\u201327.","journal-title":"Braz J Med Biol Res"},{"key":"3279_CR14","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1038\/sj.cdd.4402128","volume":"14","author":"SB Jacobs","year":"2007","unstructured":"Jacobs SB, Basak S, Murray JI, Pathak N, Attardi LD. Siva is an apoptosis-selective p53 target gene important for neuronal cell death. Cell Death Differ. 2007;14:1374\u201385.","journal-title":"Cell Death Differ"},{"key":"3279_CR15","doi-asserted-by":"publisher","first-page":"26964","DOI":"10.1074\/jbc.M109.036293","volume":"284","author":"DL Cottle","year":"2009","unstructured":"Cottle DL, McGrath MJ, Wilding BR, Cowling BS, Kane JM, D\u2019Arcy CE, et al. SLIMMER (FHL1B\/KyoT3) interacts with the proapoptotic protein Siva-1 (CD27BP) and delays skeletal myoblast apoptosis. J Biol Chem. 2009;284:26964\u201377.","journal-title":"J Biol Chem"},{"key":"3279_CR16","doi-asserted-by":"publisher","first-page":"11465","DOI":"10.1074\/jbc.C100050200","volume":"276","author":"C Cao","year":"2001","unstructured":"Cao C, Ren X, Kharbanda S, Koleske AJ, Prasad KV, Kufe D. The ARG tyrosine kinase interacts with Siva-1 in the apoptotic response to oxidative stress. J Biol Chem. 2001;276:11465\u20138.","journal-title":"J Biol Chem"},{"key":"3279_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1023\/B:APPT.0000012125.01799.4c","volume":"9","author":"F Chu","year":"2004","unstructured":"Chu F, Borthakur A, Sun X, Barkinge J, Gudi R, Hawkins S, et al. The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis. Apoptosis. 2004;9:83\u201395.","journal-title":"Apoptosis"},{"key":"3279_CR18","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.1158\/0008-5472.CAN-04-3270","volume":"65","author":"F Chu","year":"2005","unstructured":"Chu F, Barkinge J, Hawkins S, Gudi R, Salgia R, Kanteti PV. Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2. Cancer Res. 2005;65:5301\u20139.","journal-title":"Cancer Res"},{"key":"3279_CR19","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/leu.2016.293","volume":"31","author":"IK Park","year":"2017","unstructured":"Park IK, Blum W, Baker SD, Caligiuri MA. E3 ubiquitin ligase Cbl-b activates the p53 pathway by targeting Siva1, a negative regulator of ARF, in FLT3 inhibitor-resistant acute myeloid leukemia. Leukemia. 2017;31:502\u201305.","journal-title":"Leukemia"},{"key":"3279_CR20","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1172\/JCI130015","volume":"130","author":"M Palrasu","year":"2020","unstructured":"Palrasu M, Zaika E, El-Rifai W, Garcia-Buitrago M, Piazuelo MB, Wilson KT, et al. Bacterial CagA protein compromises tumor suppressor mechanisms in gastric epithelial cells. J Clin Invest. 2020;130:2422\u201334.","journal-title":"J Clin Invest"},{"key":"3279_CR21","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.2147\/OTT.S173001","volume":"11","author":"J Vachtenheim Jr.","year":"2018","unstructured":"Vachtenheim J Jr., Lischke R, Vachtenheim J. Siva-1 emerges as a tissue-specific oncogene beyond its classic role of a proapoptotic gene. Onco Targets Ther. 2018;11:6361\u201367.","journal-title":"Onco Targets Ther"},{"key":"3279_CR22","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1158\/2159-8290.CD-14-0921","volume":"5","author":"JL Van Nostrand","year":"2015","unstructured":"Van Nostrand JL, Brisac A, Mello SS, Jacobs SB, Luong R, Attardi LD. The p53 Target Gene SIVA Enables Non-Small Cell Lung Cancer Development. Cancer Discov. 2015;5:622\u201335.","journal-title":"Cancer Discov"},{"key":"3279_CR23","doi-asserted-by":"publisher","first-page":"12851","DOI":"10.1073\/pnas.1017372108","volume":"108","author":"N Li","year":"2011","unstructured":"Li N, Jiang P, Du W, Wu Z, Li C, Qiao M, et al. Siva1 suppresses epithelial-mesenchymal transition and metastasis of tumor cells by inhibiting stathmin and stabilizing microtubules. Proc Natl Acad Sci USA. 2011;108:12851\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3279_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0092-7","volume":"31","author":"X Wen","year":"2014","unstructured":"Wen X, Zhu J, Dong L, Chen Y. The role of c2orf68 and PI3K\/Akt\/mTOR pathway in human colorectal cancer. Med Oncol. 2014;31:92.","journal-title":"Med Oncol"},{"key":"3279_CR25","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/2111190b0","volume":"211","author":"I Morris","year":"1966","unstructured":"Morris I. Inhibition of protein synthesis by cyclo-heximide (actidione) in chlorella. Nature. 1966;211:1190\u201392.","journal-title":"Nature"},{"key":"3279_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1743-7563.2012.01535.x","volume":"9","author":"N Guo","year":"2013","unstructured":"Guo N, Peng Z. MG132, a proteasome inhibitor, induces apoptosis in tumor cells. Asia Pac J Clin Oncol. 2013;9:6\u201311.","journal-title":"Asia Pac J Clin Oncol"},{"key":"3279_CR27","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3324\/haematol.2014.113324","volume":"100","author":"N Yuan","year":"2015","unstructured":"Yuan N, Song L, Zhang S, Lin W, Cao Y, Xu F, et al. Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia. Haematologica. 2015;100:345\u201356.","journal-title":"Haematologica"},{"key":"3279_CR28","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1242\/jcs.049940","volume":"122","author":"U Resch","year":"2009","unstructured":"Resch U, Schichl YM, Winsauer G, Gudi R, Prasad K, de Martin R. Siva1 is a XIAP-interacting protein that balances NFkappaB and JNK signalling to promote apoptosis. J Cell Sci. 2009;122:2651\u201361.","journal-title":"J Cell Sci"},{"key":"3279_CR29","doi-asserted-by":"publisher","first-page":"28706","DOI":"10.1074\/jbc.M400376200","volume":"279","author":"A Fortin","year":"2004","unstructured":"Fortin A, MacLaurin JG, Arbour N, Cregan SP, Kushwaha N, Callaghan SM, et al. The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1. J Biol Chem. 2004;279:28706\u201314.","journal-title":"J Biol Chem"},{"key":"3279_CR30","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1158\/1535-7163.MCT-08-0893","volume":"8","author":"L Moretti","year":"2009","unstructured":"Moretti L, Kim KW, Jung DK, Willey CD, Lu B. Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitor. Mol Cancer Ther. 2009;8:1270\u20139.","journal-title":"Mol Cancer Ther"},{"key":"3279_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105297","volume":"163","author":"L Cao","year":"2021","unstructured":"Cao L, Mu W. Necrostatin-1 and necroptosis inhibition: pathophysiology and therapeutic implications. Pharm Res. 2021;163:105297.","journal-title":"Pharm Res"},{"key":"3279_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101328","volume":"28","author":"G Miotto","year":"2020","unstructured":"Miotto G, Rossetto M, Di Paolo ML, Orian L, Venerando R, Roveri A, et al. Insight into the mechanism of ferroptosis inhibition by ferrostatin-1. Redox Biol. 2020;28:101328.","journal-title":"Redox Biol"},{"key":"3279_CR33","first-page":"1693s","volume":"59","author":"SJ Korsmeyer","year":"1999","unstructured":"Korsmeyer SJ. BCL-2 gene family and the regulation of programmed cell death. Cancer Res. 1999;59:1693s\u2013700s.","journal-title":"Cancer Res"},{"key":"3279_CR34","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1038\/cdd.2012.11","volume":"19","author":"C Iorio-Morin","year":"2012","unstructured":"Iorio-Morin C, Germain P, Roy S, G\u00e9nier S, Labrecque P, Parent JL. Thromboxane A2 modulates cisplatin-induced apoptosis through a Siva1-dependent mechanism. Cell Death Differ. 2012;19:1347\u201357.","journal-title":"Cell Death Differ"},{"key":"3279_CR35","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.3892\/ol.2017.6307","volume":"14","author":"Y Ma","year":"2017","unstructured":"Ma Y, Liu T, Song X, Tian Y, Wei Y, Wang J, et al. Siva 1 inhibits proliferation, migration and invasion by phosphorylating Stathmin in ovarian cancer cells. Oncol Lett. 2017;14:1512\u201318.","journal-title":"Oncol Lett"},{"key":"3279_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0959-440X(00)00167-6","volume":"11","author":"JH Laity","year":"2001","unstructured":"Laity JH, Lee BM, Wright PE. Zinc finger proteins: new insights into structural and functional diversity. Curr Opin Struct Biol. 2001;11:39.","journal-title":"Curr Opin Struct Biol"},{"key":"3279_CR37","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s10822-021-00413-6","volume":"35","author":"MY Hamed","year":"2021","unstructured":"Hamed MY, Siam R, Zaid R. The role of zinc finger linkers in zinc finger protein binding to DNA. J Comput Aided Mol Des. 2021;35:973\u201386.","journal-title":"J Comput Aided Mol Des"},{"key":"3279_CR38","first-page":"1918","volume":"41","author":"Z Lv","year":"2019","unstructured":"Lv Z, He K, Shi L, Shi K, Jiang T, Chen Y. Interaction between C2ORF68 and HuR in human colorectal cancer. Oncol Rep. 2019;41:1918\u201328.","journal-title":"Oncol Rep"},{"key":"3279_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2533","volume":"4","author":"X Wang","year":"2013","unstructured":"Wang X, Zha M, Zhao X, Jiang P, Du W, Tam AY, et al. Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase. Nat Commun. 2013;4:1551.","journal-title":"Nat Commun"},{"key":"3279_CR40","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nature03579","volume":"435","author":"T Oltersdorf","year":"2005","unstructured":"Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 2005;435:677\u201381.","journal-title":"Nature"},{"key":"3279_CR41","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41418-024-01417-z","volume":"32","author":"C Alcon","year":"2025","unstructured":"Alcon C, Kovatcheva M, Morales-S\u00e1nchez P, L\u00f3pez-Polo V, Torres T, Puig S, et al. HRK downregulation and augmented BCL-xL binding to BAK confer apoptotic protection to therapy-induced senescent melanoma cells. Cell Death Differ. 2025;32:646\u201356.","journal-title":"Cell Death Differ"},{"key":"3279_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03635-w","volume":"20","author":"C Zhao","year":"2022","unstructured":"Zhao C, Yang ZY, Zhang J, Li O, Liu SL, Cai C, et al. Inhibition of XPO1 with KPT-330 induces autophagy-dependent apoptosis in gallbladder cancer by activating the p53\/mTOR pathway. J Transl Med. 2022;20:434.","journal-title":"J Transl Med"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03279-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03279-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03279-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:25:32Z","timestamp":1791555932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03279-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3279"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03279-5","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal and human tissue procedures were approved by the institutional ethics committee of Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (Approval No. XHEC-NSFC-2023-214). All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"413"}}